EDGAR Filing Documents for 0001564590-16-020529

Form 8-K - Current report:

SEC Accession No. 0001564590-16-020529

Filing Date

2016-06-13

Accepted

2016-06-13 16:05:25

Documents

Period of Report

2016-06-10

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	ctmx-8k_20160610.htm	8-K	71313
2	EX-99.1	ctmx-ex991_6.htm	EX-99.1	8153
3	GRAPHIC	gd3a2ihfrhs4000001.jpg	GRAPHIC	4559
	Complete submission text file	0001564590-16-020529.txt		87240

Mailing Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080

Business Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080 650.515.3185

CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)